KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other financing activities (2018 - 2023)

Pacific Biosciences Of California has reported Other financing activities over the past 6 years, most recently at $50000.0 for Q4 2023.

  • Quarterly results put Other financing activities at $50000.0 for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2024 was $539000.0 (down 86.8% YoY), and the annual figure for FY2023 was $7.4 million, changed.
  • Other financing activities for Q4 2023 was $50000.0 at Pacific Biosciences Of California, down from $489000.0 in the prior quarter.
  • Over the last five years, Other financing activities for PACB hit a ceiling of $32.2 million in Q4 2020 and a floor of -$30.1 million in Q4 2021.
  • Median Other financing activities over the past 5 years was $1.4 million (2019), compared with a mean of $3.9 million.
  • Biggest five-year swings in Other financing activities: soared 24469.47% in 2020 and later tumbled 193.59% in 2021.
  • Pacific Biosciences Of California's Other financing activities stood at $131000.0 in 2019, then soared by 24469.47% to $32.2 million in 2020, then plummeted by 193.59% to -$30.1 million in 2021, then skyrocketed by 111.76% to $3.5 million in 2022, then crashed by 98.59% to $50000.0 in 2023.
  • The last three reported values for Other financing activities were $50000.0 (Q4 2023), $489000.0 (Q3 2023), and $3.5 million (Q3 2022) per Business Quant data.